Bisphosphonates do not reduce breast cancer risk

August 13, 2014 1:25 AM

4 0

An analysis of data from two randomized clinical trials finds that three to four years of treatment with bisphosphonates to improve bone density is not linked to reduced risk of invasive postmenopausal breast cancer.

The authors are Trisha F. Hue, Ph.D., M.P.H., of the University of California, San Francisco, and colleagues.

Read more

To category page

Loading...